GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
318 hedge funds and large institutions have $4.35B invested in GW Pharmaceuticals Plc American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 107 increasing their positions, 78 reducing their positions, and 47 closing their positions.
37% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 78
10% more capital invested
Capital invested by funds: $3.94B → $4.35B (+$412M)
6% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 47
1% less funds holding
Funds holding: 320 → 318 (-2)
26% less call options, than puts
Call options by funds: $134M | Put options by funds: $181M
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$110M |
| 2 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$99.7M |
| 3 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$97M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$94.3M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$58.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$126M |
| 2 |
Barclays
London,
United Kingdom
|
-$35.7M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$21.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$20.7M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$19.5M |
GWPH Hedge Fund Activity: Q2 2019 in Review
318 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2019, worth a combined $4.35B — up 10% from $3.94B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new GWPH positions and 47 closed out — a net gain of 3 holders — while 107 added to existing stakes and 78 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $110M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $126M sold.
- 318 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2019, down from 320 in Q1 2019.
- Funds reported $4.35B of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2019, up 10% quarter-over-quarter.
- 50 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2019 and 47 closed out, a net change of +3 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q2 2019 was Point72 Asset Management, an estimated $110M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2019 was Scopia Capital Management, an estimated $126M sold.
Based on aggregated 13F filings for Q2 2019.